Clinical Trial Update: K-924 Phase III Confirmatory Study [Phase 3]

View source ↗

Summary

A Phase III confirmatory study of K-924 in hypercholesterolemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• K-924

Snippet

Sponsor: Kowa Company, Ltd. | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED